Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 334 followers
Latest posts
Last updated about 6 hours ago
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 34, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of...
Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of authorisation: 30/01/2014, Revision: 33, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Date of...
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 12, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation...
Clinical Trials Information System (CTIS): Walk-in clinic October 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 7 October 2026, 16:00 (CEST) to 7 October 2026, 17:00 (CEST)
about 12 hours ago
Clinical Trials Information System (CTIS): Walk-in clinic October 2026, Online, European Medicines...
HMPC: overview of assessment work - priority list
about 13 hours ago
HMPC: overview of assessment work - priority list
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 4, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation...
Summary of opinion: Jivi, 23/07/2026 Positive
1 day ago
Summary of opinion: Jivi, 23/07/2026 Positive